AXIS Capital Holdings Limited
NYSE:AXSInsurance - Property & Casualty
-$1.03 today
- Market cap
- $7.68B
- Beta
- 0.52
- P/E (TTM)
- 7.1
- EPS (TTM)
- $14.44
- Dividend yield
- 1.72%
Volume 0.56M
Average 0.58M
AXS Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
AXIS Capital Holdings LimitedNYSE: AXS
Research & Development · Q3 FY2026 · quarter ended Sep 2026
Research & development remains negative
Q3 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How AXS compares with its peers on the latest reported figures
- AXS's LTM Sep 2026 research & development of $0 is the highest of the 11 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for AXS, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
PLGOPelagos Insurance Capital Limit | LTM Sep 2026 | $0 | — | — | 0.0% |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding AXS) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for AXS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 5.32B | 5.3B | 5.59B | 6.02B | 6.56B |
| Cost of Revenue | 3.93B | 4.26B | 4.39B | 4.23B | 3.29B |
| Gross Profit | 1.39B | 1.04B | 1.2B | 1.79B | 3.28B |
| Gross Margin | 26.1% | 19.6% | 21.4% | 29.7% | 49.9% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 663.3M | 680.34M | 684.45M | 666.2M | 703.93M |
| Operating Expenses | 741.87M | 797.25M | 798.03M | 781.54M | 2.05B |
| Depreciation & Amortization | 66.98M | 68.29M | 75.55M | 55.31M | 56.38M |
| EBITDA | 778.19M | 374.56M | 542.42M | 1.13B | 1.35B |
| EBITDA Margin | 14.6% | 7.1% | 9.7% | 18.8% | 20.5% |
| Operating Income | 648.91M | 243.13M | 398.45M | 1.01B | 1.23B |
| Operating Margin | 12.2% | 4.6% | 7.1% | 16.8% | 18.7% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 62.3M | 63.15M | 68.42M | 67.77M | 66.66M |
| Other Income / Expenses | 32.08M | 2M | 4.16M | 17.95M | 0 |
| Income Before Tax | 680.99M | 245.12M | 402.61M | 1.03B | 1.23B |
| Pre-Tax Margin | 12.8% | 4.6% | 7.2% | 17.0% | 18.7% |
| Income Tax Expense | 62.38M | 22.04M | 26.32M | (55.6M) | 216.73M |
| Net Income | 618.61M | 223.08M | 376.29M | 1.08B | 1.01B |
| Net Margin | 11.6% | 4.2% | 6.7% | 18.0% | 15.4% |
| EPS (Basic) | 6.95 | 2.27 | 4.06 | 12.49 | 12.52 |
| EPS (Diluted) | 6.90 | 2.25 | 4.02 | 12.35 | 12.35 |
| Weighted Avg Shares | 84.71M | 84.86M | 85.14M | 84.17M | 78.19M |
| Weighted Avg Shares (Diluted) | 85.29M | 85.67M | 86.01M | 85.18M | 79.27M |
AXIS Capital Holdings Limited
NYSE:AXS
Intrinsic Alpha fair value
Locked
Current Price
$107.08
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.